Clinical Trial Update: A Study of GSK573719 in Healthy Japanese Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 study of GSK573719 in healthy Japanese male subjects completed; study status updated for COPD-related investigation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK573719

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED